🇺🇸 FDA
Patent

US 8455455

Compositions and methods for silencing genes involved in hemorrhagic fever

granted A61KA61K31/713A61K47/60

Quick answer

US patent 8455455 (Compositions and methods for silencing genes involved in hemorrhagic fever) held by The United States Army Medical Research and Materiel Command expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States Army Medical Research and Materiel Command
Grant date
Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/713, A61K47/60